• Je něco špatně v tomto záznamu ?

Telomere length in bipolar disorder and lithium response

A. Squassina, C. Pisanu, N. Corbett, M. Alda,

. 2017 ; 27 (6) : 560-567. [pub] 20151124

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc18025401

Telomeres consist of exanucleotide tandem repeats and proteins complexes at the end of chromosome ends. Telomeres shorten at each cell division, and as such telomere length is a marker of cellular age. Accelerated telomere shortening and cell senescence have been associated with a number of chronic medical conditions, including psychiatric disorders, where increased prevalence of age-related disorders and shorter telomere length have been reported. Shorter telomeres in psychiatric patients are thought to be the consequence of allostatic load, consisting in the overactivation of allostatic systems due to chronic exposure to severe medical conditions and failure to adapt to chronic stressful stimuli. Most of the studies on telomere length in psychiatry have focused on major depressive disorder, but recent findings have shown shorter leukocyte telomere length in bipolar disorder patients and suggested that lithium may counteract telomeres shortening. These findings provided new insights into the pathophysiology of bipolar disorder and the mechanism of action of lithium. In this review we will present findings from the literature on telomere length in bipolar disorder, with a specific focus on lithium. We will also discuss advances and limitations of published work as well as methodological issues and potential confounding factors that should be taken into account when designing research protocols to study telomere length.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18025401
003      
CZ-PrNML
005      
20180713114623.0
007      
ta
008      
180709s2017 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.euroneuro.2015.10.008 $2 doi
035    __
$a (PubMed)26621262
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Squassina, Alessio $u Laboratory of Pharmacogenomics, Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy; Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada. Electronic address: squassina@unica.it.
245    10
$a Telomere length in bipolar disorder and lithium response / $c A. Squassina, C. Pisanu, N. Corbett, M. Alda,
520    9_
$a Telomeres consist of exanucleotide tandem repeats and proteins complexes at the end of chromosome ends. Telomeres shorten at each cell division, and as such telomere length is a marker of cellular age. Accelerated telomere shortening and cell senescence have been associated with a number of chronic medical conditions, including psychiatric disorders, where increased prevalence of age-related disorders and shorter telomere length have been reported. Shorter telomeres in psychiatric patients are thought to be the consequence of allostatic load, consisting in the overactivation of allostatic systems due to chronic exposure to severe medical conditions and failure to adapt to chronic stressful stimuli. Most of the studies on telomere length in psychiatry have focused on major depressive disorder, but recent findings have shown shorter leukocyte telomere length in bipolar disorder patients and suggested that lithium may counteract telomeres shortening. These findings provided new insights into the pathophysiology of bipolar disorder and the mechanism of action of lithium. In this review we will present findings from the literature on telomere length in bipolar disorder, with a specific focus on lithium. We will also discuss advances and limitations of published work as well as methodological issues and potential confounding factors that should be taken into account when designing research protocols to study telomere length.
650    _2
$a bipolární porucha $x krev $x diagnóza $x farmakoterapie $7 D001714
650    _2
$a lidé $7 D006801
650    _2
$a lithium $x farmakologie $x terapeutické užití $7 D008094
650    _2
$a telomery $x účinky léků $x fyziologie $7 D016615
650    _2
$a homeostáza telomer $x účinky léků $x fyziologie $7 D059505
650    _2
$a zkracování telomer $x účinky léků $x fyziologie $7 D059506
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Pisanu, Claudia $u Laboratory of Pharmacogenomics, Section of Neuroscience and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
700    1_
$a Corbett, Nathan $u The Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
700    1_
$a Alda, Martin $u Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; National Institute of Mental Health, Klecany, Czech Republic.
773    0_
$w MED00001656 $t European neuropsychopharmacology the journal of the European College of Neuropsychopharmacology $x 1873-7862 $g Roč. 27, č. 6 (2017), s. 560-567
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26621262 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20180713114917 $b ABA008
999    __
$a ok $b bmc $g 1317532 $s 1022322
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 27 $c 6 $d 560-567 $e 20151124 $i 1873-7862 $m European neuropsychopharmacology $n Eur Neuropsychopharmacol $x MED00001656
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...